Several thousand organohalogen compounds have been identified as biosynthetic products from living organisms. 1 Although the oceans are the single largest source of naturally occurring organohalogens, some terrestrial organisms such as plants, fungi, bacteria, insects and lichens have also been identified as producers of halogenated natural products. 2 Less than 45 organohalogens containing the 3-chloro-4-hydroxyphenyl subunit have been isolated from natural sources to date. [3] [4] [5] [6] [7] [8] We have recently embarked on a research program looking for new chemistry and bioactive metabolites from microfungi isolated from Australian endemic plants. Examination of a local rainforest tree, Glochidion ferdinandi (family Euphorbiaceae) afforded several microfungal strains, one of which was identified as Xylaria sp. (FRR 5657).
9
This strain, when cultured on damp rice produced two new xanthones 9 but when grown in malt extract broth the EtOAc extract yielded, via C18 flash chromatography then phenyl HPLC, the new natural product 3-chloro-4-hydroxyphenylacetamide 1 and the previously reported fungal metabolite, 3-chloro-4-hydroxyphenylacetic acid 2.
10
The previously isolated xanthones 9 were not produced in the malt extract broth cultures.
Compound 1 was assigned the molecular formula C 8 H 8 NO 2 Cl on the basis of HREIMS, C NMR spectral data (see Table 1 ). The (-)-LRESIMS isotopic pattern C NMR spectral data (see Table 1 ). The 13 C NMR spectrum of 2 was essentially identical to 1, with only small discrepancies observed (< 1.7 ppm). The 1 H NMR spectrum of 2 also showed similarities with 1, however the exchangeable primary amide signals of 1 were replaced with only one broad exchangeable proton signal at These data suggested that the primary amide in 1 had been substituted with a carboxylic acid in 2. Hence compound 2 was determined to be 3-chloro-4-hydroxyphenylacetic acid. This compound has been previously reported as a metabolite from the fungus Marasmius palmivorus 17 however its isolation and full spectroscopic charaterisation was not published. Compound 2 is also commercially available and we confirmed by NMR, IR, UV and MS analyses that the natural product was identical to the synthetic material.
The first reported synthesis of 1 involved several steps with the final reaction involving the hydrolysis and dealkylation of an alkoxy protected chlorinated phenyl acetonitrile. 15 We synthesised 1 from 2 in a one-pot reaction using peptide coupling chemistry.
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Synthetic 1 was spectroscopically identical in all respects to the natural product.
Compounds 1 and 2 were both tested for cytotoxicity against the cell lines SHSY5Y
(human neuroblastoma), HEK293T (SV40 T antigen transformed human embryonal kidney cells), and A549 (human non-small cell lung carcinoma) using the colourimetric sulphorhodamine B assay.
19
Compounds 1 and 2 showed no cytotoxicity when tested at 2 and 20 μg/mL.
In conclusion, this paper reports the isolation, structure elucidation, crystal structure and one-pot synthesis of the new natural product 3-chloro-4-hydroxyphenylacetamide 1. The previously reported fungal metabolite 3-chloro-4-hydroxyphenylacetic acid 2 was also isolated and spectroscopically characterised using NMR, UV, IR and MS data. 
